Literature DB >> 15927431

Effect of double antigen bridging immunoassay format on antigen coating concentration dependence and implications for designing immunogenicity assays for monoclonal antibodies.

James S Bourdage1, Thomas N Lee, J Michael Taylor, Mark B Willey, John T Brandt, Robert J Konrad.   

Abstract

The double antigen bridging immunoassay has been used extensively for detection of immunogenicity responses to therapeutic monoclonal antibodies. We have analyzed parameters affecting performance of this type of immunoassay including microtiter plate antigen coating concentration, enzyme-labeled antigen conjugate dilution and assay format (one-step versus two-step). We present results demonstrating that the format of the assay has a significant impact on the optimal parameters to maximize assay performance. A one-step assay format achieves maximal sensitivity across a broad range of coating concentrations and at a lower concentration of conjugate than that in a two-step format. In contrast, a two-step format requires very low coating concentrations and higher conjugate concentrations to achieve maximal sensitivity and suffers from significantly reduced sensitivity at higher coating concentrations. Together, these findings indicate that a one-step assay format can greatly reduce the effect of coating concentration variation on assay performance.

Mesh:

Substances:

Year:  2005        PMID: 15927431     DOI: 10.1016/j.jpba.2005.03.037

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  5 in total

1.  Recombinant Anti-idiotypic Antibodies in Ligand Binding Assays for Antibody Drug Development.

Authors:  Stefan Harth; Christian Frisch
Journal:  Methods Mol Biol       Date:  2021

Review 2.  Review on modeling anti-antibody responses to monoclonal antibodies.

Authors:  José David Gómez-Mantilla; Iñaki F Trocóniz; Zinnia Parra-Guillén; María J Garrido
Journal:  J Pharmacokinet Pharmacodyn       Date:  2014-07-16       Impact factor: 2.745

3.  Generation by phage display and characterization of drug-target complex-specific antibodies for pharmacokinetic analysis of biotherapeutics.

Authors:  Stefan Harth; Andre Ten Haaf; Christian Loew; Christian Frisch; Achim Knappik
Journal:  MAbs       Date:  2018-12-05       Impact factor: 5.857

4.  A simple and fast non-radioactive bridging immunoassay for insulin autoantibodies.

Authors:  Ingrid Kikkas; Roberto Mallone; Nadia Tubiana-Rufi; Didier Chevenne; Jean Claude Carel; Christophe Créminon; Hervé Volland; Christian Boitard; Nathalie Morel
Journal:  PLoS One       Date:  2013-07-29       Impact factor: 3.240

5.  How the immune system responds to therapeutic biological agents.

Authors:  Alessandra Vultaggio; Giulia Petroni; Sara Pratesi; Francesca Nencini; Daniele Cammelli; Andrea Ferraro; Enrico Maggi; Andrea Matucci
Journal:  J Int Med Res       Date:  2016-09       Impact factor: 1.671

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.